The No Surprises Act (NSA) places regulatory requirements on health providers and insurers. It’s designed to protect consumers from unanticipated and high-cost payments for out-of-network emergency treatment by prohibiting balance billing. Additionally, it provides consumers with the right to a good-faith cost estimate (GFE) before scheduled services and access to the Patient Provider Dispute Resolution Process (“PPDR”).
Join us, along with our cohost, Moss Adams, for the second segment of this two-part series, The No Surprises Act, Part Two: The Good Faith Estimate and Patient Provider Dispute Resolution. We’ll cover key elements of the NSA, areas of risk, as well as the following topics:
- The ever-changing implications and compliance requirements of the NSA
- Key strategies to prepare and stay compliant
- Unintended consequences of the NSA and gray areas that impact health care providers
People
Related Insights
June 3, 2025
Foley Corporate Governance Update
Texas Senate Bill 2337: Protecting Texas Companies and Their Directors, Shareholders and Boards from Proxy Advice Not in the Financial Interests of Shareholders
On June 2, 2025, the Texas Legislature passed Senate Bill 2337, meaningfully regulating proxy advisors like ISS and Glass Lewis when providing proxy voting recommendations concerning Texas companies.
September 25, 2025
Events
Unclaimed Property Roundtable with Delaware State Escheator and Leading Practitioners
June 3, 2025
Health Care Law Today
GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health
Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.